Predictors of successful closure of patent ductus arteriosus with indomethacin

J Perinatol. 2015 Sep;35(9):729-34. doi: 10.1038/jp.2015.33. Epub 2015 Apr 9.

Abstract

Objective: To determine whether platelet counts can predict the likelihood of successful closure of patent ductus arteriosus (PDA) with indomethacin.

Study design: This was a retrospective cohort study of infants <32 weeks' gestational age (GA) and birth weight <1500 g with PDA. Clinical characteristics between infants who achieved ductal closure with indomethacin and those who failed were compared. Multivariable logistic regression was used to identify predictors of successful ductal closure.

Results: In infants with hemodynamically significant PDA, older GA (odds ratio=1.54; 95% confidence interval: 1.12 to 2.13), male gender (odds ratio=3.02; 95% confidence interval: 1.08 to 8.49) and higher platelet count (odds ratio=1.5; 95% confidence interval: 1.04 to 2.17) prior to indomethacin treatment were associated with successful ductal closure with indomethacin.

Conclusion: Older GA, male gender and higher platelet count at time of treatment of hemodynamically significant PDA are predictors of successful ductal closure with indomethacin.

Publication types

  • Observational Study

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Cohort Studies
  • Ductus Arteriosus, Patent* / blood
  • Ductus Arteriosus, Patent* / diagnosis
  • Ductus Arteriosus, Patent* / drug therapy
  • Ductus Arteriosus, Patent* / physiopathology
  • Female
  • Gestational Age
  • Hemodynamics / drug effects*
  • Humans
  • Indomethacin / administration & dosage*
  • Infant, Low Birth Weight / physiology
  • Infant, Newborn
  • Infant, Premature / physiology
  • Logistic Models
  • Male
  • Platelet Count / statistics & numerical data*
  • Retrospective Studies
  • Sex Factors
  • Treatment Outcome
  • United States / epidemiology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Indomethacin